KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Receivables: 2017-2025

Historic Change in Receivables for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$14.5 million.

  • Guardant Health's Change in Receivables fell 19.92% to -$14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year increase of 8386.23%. This contributed to the annual value of $21.4 million for FY2024, which is 355.30% up from last year.
  • As of Q3 2025, Guardant Health's Change in Receivables stood at -$14.5 million, which was down 201.01% from $14.3 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Change in Receivables ranged from a high of $36.9 million in Q4 2021 and a low of -$14.5 million during Q3 2025.
  • For the 3-year period, Guardant Health's Change in Receivables averaged around $1.7 million, with its median value being $1.7 million (2023).
  • Its Change in Receivables has fluctuated over the past 5 years, first tumbled by 3,038.55% in 2021, then spiked by 120,683.33% in 2024.
  • Guardant Health's Change in Receivables (Quarterly) stood at $36.9 million in 2021, then slumped by 70.04% to $11.1 million in 2022, then slumped by 100.16% to -$18,000 in 2023, then soared by 120,683.33% to $21.7 million in 2024, then fell by 19.92% to -$14.5 million in 2025.
  • Its Change in Receivables was -$14.5 million in Q3 2025, compared to $14.3 million in Q2 2025 and $6.1 million in Q1 2025.